와이투솔루션

고객센터

보도자료 및 공지사항

룩사 바이오 첫환자 투약 보도자료 2022-06-15

룩사바이오 건성황반변성 치료제 개발 임상 Phase1/2a 첫환자 투약

https://www.businesswire.com/news/home/20220524005126/en/

https://www.biospace.com/article/releases/luxa-bio-announces-first-participant-dosed-in-phase-1-2a-clinical-trial-of-adult-rpesc-rpe-4w-for-dry-age-related-macular-degeneration/

https://finance.yahoo.com/news/luxa-bio-announces-first-participant-120000860.html

https://www.fightingblindness.org/research/luxa-doses-first-participant-in-clinical-trial-of-rpe-stem-cells-for-dry-amd-patients-260

https://pharma-trend.com/en/luxa-bio-announces-first-participant-dosed-in-phase-1-2a-clinical-trial-of-adult-rpesc-rpe-4w-for-dry-age-related-macular-degeneration/

https://www.iqstock.news/n/luxa-bio-announces-participant-dosed-phase-2a-clinical-trial-adult-rpesc-rpe-3944173/

보도자료_와이투솔루션_클린일렉스_국책과제선정

외부감사인 계약의 건